Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 Biomarker disease BEFREE The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus. 30858202 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 Biomarker disease BEFREE Confirmation of methicillin-resistant Staphylococcus aureus (MRSA) was performed using multiplex PCR targeting mecA and nuc genes in addition to phenotypic assay based on PBP-2a latex agglutination. 26178302 2016
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 GeneticVariation disease BEFREE In this study, two clonal complex 130 (CC130) methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients in Irish hospitals were identified that were phenotypically PBP 2a positive but lacked mecA by conventional PCR and by DNA microarray screening. 21636525 2011
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 Biomarker disease BEFREE Phenotypically identified methicillin resistant Staphylococcus aureus (MRSA) strains from several hospitals in Romania and Saudi Arabia (n = 103 and 68, respectively) were confirmed to be MRSA by mecA PCR and PBP-2' based latex agglutination. 16168939 2005
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 Biomarker disease BEFREE The present study compared the MRSA-Screen latex agglutination test (Denka Seiken Co., Ltd., Tokyo, Japan) for detection of PBP 2a with agar dilution, the VITEK-1 and VITEK-2 systems (bioMérieux, St. Louis, Mo.), and the oxacillin agar screen test for detection of MRSA, with PCR for the mecA gene used as the "gold standard" assay. 11682512 2001
MRSA - Methicillin resistant Staphylococcus aureus infection
0.060 Biomarker disease BEFREE Moreover, a 4.3 kb HindIII fragment containing MRSA-PBP gene was detected by using the same oligonucleotide probe. 2048117 1991